James E. Levine insider trades

Open-market stock purchases and sales by James E. Levine, Chief Financial Officer at Kazia Therapeutics Ltd, from SEC Form 4 filings since Nov 12, 2009.

Track record: 0% of 5 scored buys are up 5% or more since purchase, averaging -60%.

Recent trades

DateStockTradeValue
Jun 19, 2026KZIA Kazia Therapeutics LtdBought (not open market)—

Companies traded

  • KZIA Kazia Therapeutics Ltd: other filings, last Jun 19, 2026
  • CRDF Cardiff Oncology, Inc: 6 buys, last Mar 11, 2025
  • CDTX Cidara Therapeutics, Inc: 3 buys, last Mar 17, 2021
  • VRNM Verenium Corp: 5 buys, last Oct 31, 2013

Get free alerts when James E. Levine files a new trade →